Trial
NCT01332331
Efficacy and Safety of Ambrisentan in Children 8-18yrs
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Hypertension, Pulmonary
Intervention
Ambrisentan - low dose
Why stopped
Ongoing juvenile rat toxicology studies.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-08